Open AccessThe effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study
Author(s) -
Lauren E. Cain,
Andrew Phillips,
Sara Lodi,
Caroline Sabin,
Loveleen Bansi,
Amy C. Justice,
Janet P. Tate,
Roger Logan,
James M. Robins,
Jonathan A C Sterne,
Ard van Sighem,
Frank de Wolf,
Heiner C. Bucher,
Luigia Elzi,
Giota Touloumi,
Georgia Vourli,
Anna Esteve,
Jordi Casabona,
Julia del Amo,
Santiago Moreno,
Rémonie Seng,
Laurence Meyer,
S. PérezHoyos,
Roberto Muga,
Sophie Abgrall,
Dominique Costagliola,
Miguel A. Hernán
Publication year - 2012
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328354f497
Subject(s) - nevirapine , efavirenz , observational study , medicine , prospective cohort study , reverse transcriptase inhibitor , sida , virology , human immunodeficiency virus (hiv) , immunology , viral load , antiretroviral therapy , viral disease
To compare regimens consisting of either efavirenz or nevirapine and two or more nucleoside reverse transcriptase inhibitors (NRTIs) among HIV-infected, antiretroviral-naive, and AIDS-free individuals with respect to clinical, immunologic, and virologic outcomes.